Breaking News

AstraZeneca UK, Ltd. v. Atchley

Pending petition
Docket No. Op. Below Argument Opinion Vote Author Term

Issues: (1) Whether the court should grant, vacate, and remand this case for further proceedings in light of its decision in Twitter, Inc. v. Taamneh; (2) whether plaintiffs plead proximate causation as required for direct liability under the Anti-Terrorism Act by alleging that defendants transacted with a foreign-government agency that was in turn infiltrated by the group that injured plaintiffs; and (3) whether a U.S.-designated foreign terrorist organization “plan[s]” or “authorize[s]” a specific attack—as required for ATA aiding-and-abetting liability—by providing general support or inspiration to a different group that carries out the attack. CVSG: 5/21/2024

DateProceedings and Orders (key to color coding)
Apr 03 2023Application (22A868) to extend the time to file a petition for a writ of certiorari from May 4, 2023 to July 3, 2023, submitted to The Chief Justice.
Apr 06 2023Application (22A868) granted by The Chief Justice extending the time to file until July 2, 2023.
Jun 30 2023Petition for a writ of certiorari filed. (Response due August 4, 2023)
Jul 25 2023Motion to extend the time to file a response from August 4, 2023 to August 23, 2023, submitted to The Clerk.
Jul 26 2023Motion to extend the time to file a response is granted and the time is extended to and including August 23, 2023.
Aug 04 2023Brief amici curiae of Chamber of Commerce of the United States of America, et al. filed.
Aug 23 2023Brief of respondents Joshua Atchley, et al. in opposition filed.
Sep 06 2023DISTRIBUTED for Conference of 9/26/2023.
Sep 06 2023Reply of petitioners AstraZeneca UK Limited, et al. filed. (Distributed)
Oct 02 2023The Solicitor General is invited to file a brief in this case expressing the views of the United States. Justice Alito took no part in the consideration of this petition.
May 21 2024Brief amicus curiae of United States filed.